141 related articles for article (PubMed ID: 6156295)
1. [Leukocyte migration inhibition test for functional evaluation of the T-lymphocyte population].
Bilynskaia KhZ; Loginskiĭ VE
Lab Delo; 1980; (5):316-7. PubMed ID: 6156295
[No Abstract] [Full Text] [Related]
2. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
Skopińska E; Lukasik R
Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
[TBL] [Abstract][Full Text] [Related]
3. [Agarose test of leukocyte migration inhibition].
Kaszubowski P; Wysocki J
Wiad Lek; 1979 Nov; 32(22):1621-3. PubMed ID: 395757
[No Abstract] [Full Text] [Related]
4. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
5. Monocyte regulation of lymphokine production in cancer patients.
Kowalczyk D; Ruggiero I; Zembala M
J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
[TBL] [Abstract][Full Text] [Related]
6. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.
Kobayashi Y; Asada M; Higuchi M; Osawa T
J Immunol; 1982 Jun; 128(6):2714-8. PubMed ID: 7042845
[TBL] [Abstract][Full Text] [Related]
7. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
Weisbart RH; Billing R
Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
[TBL] [Abstract][Full Text] [Related]
8. Human T cell subsets differ in their ability to migrate in vitro and to produce T cell migration inhibitory factor.
Kowalczyk D; Pryjma J; Zembala M
Immunol Lett; 1986 Aug; 13(1-2):33-8. PubMed ID: 2944820
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
Crivii SM; Crişan M; Crişan M
Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis of leukocyte migration inhibition factor in pulmonary tuberculosis patients with concomitant drug intolerance].
Alenova AKh; Autenshlius AI; Mardanov SK
Probl Tuberk; 1983 Jul; (7):34-8. PubMed ID: 6356125
[No Abstract] [Full Text] [Related]
11. Does macrophage production of interferon after alloantigen stimulation depend on factors from activated T lymphocytes?
Landolfo S; Marcucci F; Giovarelli M; Forni G
Transplantation; 1980; 29(1):87-9. PubMed ID: 6154350
[No Abstract] [Full Text] [Related]
12. Participation of a histamine-Sepharose-adherent subpopulation of human mononuclear cells in the production of leucocyte migration inhibition factor (LIF) in healthy children.
Reichman BL; Handzel ZT; Segal S; Weinstein Y; Levin S
Clin Exp Immunol; 1979 Sep; 37(3):562-6. PubMed ID: 389498
[TBL] [Abstract][Full Text] [Related]
13. Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay.
Szigeti R; Stevens D; Ernberg I; Klein G; Masucci MG; Svedmyr E; Klein E
J Immunol Methods; 1981; 46(3):369-74. PubMed ID: 6273472
[TBL] [Abstract][Full Text] [Related]
14. Suppression of LIF production but not blastogenesis in patients with tuberculous meningitis.
Joffe MI; Rabson AR
Clin Immunol Immunopathol; 1981 Feb; 18(2):245-53. PubMed ID: 7008992
[No Abstract] [Full Text] [Related]
15. Human lymphocytes produce both leukocyte migration inhibition (LIF) and stimulation (MStF) factors after mitogen, alloantigens or antigen activation.
Favila-Castillo L; Méndez-Samperio P; Cortés-Castillo MA; Sánchez-Ortega A
Rev Latinoam Microbiol; 1988; 30(2):111-5. PubMed ID: 3064229
[No Abstract] [Full Text] [Related]
16. Cellular interactions in spontaneous or autologous cell-induced proliferative and lymphokine responses of human lymphocytes.
Arvilommi H; Räsänen L
Immunology; 1980 Aug; 40(4):695-700. PubMed ID: 6448804
[TBL] [Abstract][Full Text] [Related]
17. Impaired cellular interactions involving lymphocytes from patients with chronic lymphocytic leukemia and ataxia-telangiectasia.
Weisbart RH; Kacena A; Golde DW; Costea NV
J Lab Clin Med; 1980 Jul; 96(1):114-8. PubMed ID: 6993592
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF).
McCoy JL; Braatz JA; Ames RS; Herberman RB
J Immunol; 1980 Jun; 124(6):2786-93. PubMed ID: 6989906
[No Abstract] [Full Text] [Related]
19. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors.
Bendtzen K; Mahoney R; Rocklin RE
Clin Immunol Immunopathol; 1981 Feb; 18(2):212-20. PubMed ID: 7008991
[No Abstract] [Full Text] [Related]
20. [The functional characteristics of the interaction of lymphokine-producing lymphocytes with granulocytes of the peripheral blood and skin in dermatosis patients].
Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV
Vestn Dermatol Venerol; 1990; (3):29-32. PubMed ID: 2195796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
